Stay informed with the latest mpox (formerly monkeypox) updates from the AMA.
Featured updates
Featured updates
- Aug.14, 2024: WHO MPOX Public Health Emergency: WHO Director-General determined the upsurge of mpox in the Democratic Republic of the Congo (DRC) and a growing number of countries in Africa constitutes a public health emergency of international concern (PHEIC)
- Aug. 7, 2024: CDC HAN Health Advisory: Mpox Caused by Human-to-Human Transmission of Monkeypox Virus in the Democratic Republic of the Congo with Spread to Neighboring Countries
2023
- Dec. 7, 2023: Mpox Caused by Human-to-Human Transmission of Monkeypox Virus with Geographic Spread in the Democratic Republic of the Congo
2022
- Oct. 6, 2022: CDC COCA Call: Situational Update for Clinicians about Severe Monkeypox Virus Infections
- Sept. 29, 2022: CDC HAN Health Advisory: Severe Manifestations of Monkeypox among People who are Immunocompromised Due to HIV or Other Conditions
- Aug. 11, 2022: CDC COCA Call: Interim Clinical Considerations for Monkeypox Vaccination
- Aug. 8, 2022: FDA news release: FDA authorizes emergency use of JYNNEOS vaccine
- July 27, 2022: Letter from CDC Director Rochelle Walensky, MD: Pain emerging as major issue with monkeypox infection; basic tools for managing the infection (PDF)
Clinical information and resources
Clinical information and resources
Find FAQs for physicians—including MPV testing and therapeutics—CDC guidance, CPT coding and more. Track the trends of cases reported to CDC.
Video updates with AMA
Video updates with AMA
AMA Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, discusses recent mpox activity and the CDC's health advisory.
Find more
Find more
- Aug. 7, 2024: AMA Update discusses the growing mpox outbreak in Africa.
- May 22, 2024: A discussion on the latest outbreak in the Democratic Republic of Congo and mpox symptoms.
- May 8, 2024: Learn more about the mpox clade 1 outbreak.
- Sept. 13, 2022: What physicians need to know about tecovirimat (TPOXX) for treatment of mpox.
- Experts from the AMA, FDA and CDC discuss tecovirimat, or TPOXX, for the treatment of mpox in infected individuals.
- July 14, 2022: Mpox treatment and prevention with two CDC experts.
Stories of Care podcasts
- Health Disparities and Clinical Challenges of Mpox, CDC’s Project Firstline
- Mpox Infection Prevention and Control in Health Care Settings, CDC’s Project Firstline
